0000313143-13-000195.txt : 20131114
0000313143-13-000195.hdr.sgml : 20131114
20131114175129
ACCESSION NUMBER: 0000313143-13-000195
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131113
FILED AS OF DATE: 20131114
DATE AS OF CHANGE: 20131114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0330
BUSINESS ADDRESS:
STREET 1: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HANLON SUSAN M
CENTRAL INDEX KEY: 0001221862
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 131221769
MAIL ADDRESS:
STREET 1: HAEMONETICS CORPORATION
STREET 2: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-11-13
0
0000313143
HAEMONETICS CORP
HAE
0001221862
HANLON SUSAN M
400 WOOD ROAD
BRAINTREE
MA
02184
0
1
0
0
VP Finance
Common Stock
2013-11-13
4
S
0
1188.0
39.6201
D
16905
D
Non-Qualified Stock Option (right to buy)
25.535
2008-10-24
2014-10-24
Common Stock
7138
7138
D
Non-Qualified Stock Option (right to buy)
26.47
2010-10-27
2016-10-27
Common Stock
14690
14690
D
Non-Qualified Stock Option (right to buy)
27.275
2009-10-22
2015-10-22
Common Stock
7206
7206
D
Non-Qualified Stock Option (right to buy)
27.495
2011-10-27
2017-10-27
Common Stock
22348
22348
D
Non-Qualified Stock Option (right to buy)
30.67
2012-10-25
2018-10-25
Common Stock
20726
20726
D
Non-Qualified Stock Option (right to buy)
39.055
2013-10-24
2019-10-24
Common Stock
16882
16882
D
Non-Qualified Stock Option (right to buy)
41.66
2014-10-23
2023-10-23
Common Stock
18456
18456
D
Performance Shares
0.0
2017-03-31
2017-12-31
Common Stock
12500
12500
D
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).
By: Alexander Steffan For: Susan Hanlon
2013-11-14